Dr. William A. Haseltine
Cloning antibodies from recovered COVID-19 patients is showing promise as a potential treatment for the virus that has affected more than 2.8 million people worldwide and killed at least 196,000.
Dr. William A. Haseltine, Chair and President of ACCESS Health International and former Harvard Medical School professor, told uPolitics that an antibody drug could be approved in the U.S. within four months.
Despite a short mayoral campaign, Cory Bowman, Vice President JD Vance's half-brother, found his way…
President Donald Trump announced his new appointment as interim U.S. attorney for the District of…
Ford Motor Company is increasing prices on several vehicles manufactured in Mexico, citing the impact…
Concerns are rising for Sen. John Fetterman (D-Pennsylvania) following a chaotic meeting with Pennsylvania teachers'…
With weeks remaining before their self-imposed Memorial Day deadline, House Republicans are growing more divided…
The Federal Reserve decided on Wednesday to hold interest rates steady, at 4.25 percent to…
